A population-based cancer registry for the Nay Pyi Taw Union Territory, about 1.16 million people, based at Nay Pyi Taw General Hospital (1000 bedded). It recorded 5,952 new cancers and 1,874 cancer deaths in 2013 to 2017; its team wrote that Myanmar had no population-based cancer estimates before.
The registry's team, writing in the Asian Pacific Journal of Cancer Prevention in 2022, give their affiliation as the Nay Pyi Taw Cancer Registry, Nay Pyi Taw General Hospital (1000 Bedded), Department of Medical Services, Ministry of Health. They report that an International Atomic Energy Agency review, carried out with WHO and IARC under the Agency's Programme of Action for Cancer Therapy on a visit in 2015, found cancer registration to be Myanmar's top priority and recommended starting a population-based registry in Nay Pyi Taw as a first step before expanding to other states and regions, and that the registry's initial funding came from IARC under a collaborative research agreement. Staff collect cases actively from every hospital and laboratory in the territory and from death certificates held by the Central Statistical Organization's vital registration unit, and also from Yangon General Hospital, Mandalay General Hospital and the two cities' children's hospitals for Nay Pyi Taw residents treated there, and analyse them in CanReg5. The paper states that before it there were no population-based cancer incidence and mortality estimates for Myanmar.
For 2013 to 2017 the registry counted 5,952 new cancers, 2,835 in men and 3,117 in women, and 1,874 cancer deaths. Age-standardised incidence for all sites excluding non-melanoma skin cancer was 125.9 per 100,000 men and 107.3 per 100,000 women. The commonest cancers were lung, liver and mouth and pharynx in men and breast, cervix and lung in women; liver cancer caused the most cancer deaths. The authors name their own data-quality limits: 61.44% of men's and 71.04% of women's cases were morphologically verified, and 16.08% and 15.15% were known only from a death certificate.
A second regional registry, the Yangon population-based cancer registry, covered about 7.3 million people from 2018 to 2020 according to a 2025 review; its executive report for 2018, published by Vital Strategies and partners, was not found online. The coordinates are a Nay Pyi Taw city point.
The review sets out what is known about cervical cancer and human papillomavirus in Myanmar, and how little screening there had been by 2019.
It records the design and early delivery of Myanmar's cervical cancer programme as described by clinicians in Yangon.
It gives Myanmar measured, rather than extrapolated, cancer rates for one territory, and the authors read the pattern as showing a significant proportion of tobacco-related and infection-related cancers: lung, liver and mouth and pharynx cancers lead in men. It covers one territory around the capital, not the country.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Hepatocellular carcinoma, Cervical cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Cancer registries and population surveillance, Lung cancer (all types), Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Hepatocellular carcinoma, Cervical cancer.
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Lung cancer (all types), Breast cancer (all types).
Shares International Atomic Energy Agency: Rays of Hope, Hepatocellular carcinoma, Cervical cancer, Breast cancer (all types).
Shares Cancer registries and population surveillance, International Agency for Research on Cancer (IARC / WHO), Hepatocellular carcinoma, Cervical cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/